CG Oncology targets near $1 bln valuation in US IPO | Reuters
Jan 18 (Reuters) - Cancer drug developer CG Oncology said on Thursday it was targeting a valuation of nearly $1 billion for its initial public offering. The company is developing a therapy …
OFF
CG Oncology Targets Near $1 Bln Valuation In US IPO | Reuters
20 hours ago
Jan 18 (Reuters) - Cancer drug developer CG Oncology said on Thursday it was targeting a valuation of nearly $1 billion for its initial public offering. The company is developing a therapy …
reuters.com
OFF
CG Oncology Targets Near $1 Bln Valuation In US IPO
20 hours ago
Jan 18, 2024 · Adds details on company's business, IPO terms in paragraphs 2-6. Jan 18 (Reuters) - Cancer drug developer CG Oncology said on Thursday it was targeting a valuation …
nasdaq.com
OFF
UPDATE 1-CG Oncology Targets Near $1 Bln Valuation In US IPO
20 hours ago
Jan 18, 2024 · Cancer drug developer CG Oncology said on Thursday it was targeting a valuation of nearly $1 billion for its initial public offering. CG Oncology is one of a handful of companies …
yahoo.com
OFF
Cancer Drug Developer CG Oncology Targets Near $1 Bln Valuation …
20 hours ago
Jan 18, 2024 · Cancer drug developer CG Oncology said on Thursday it was targeting a valuation of nearly $1 billion for its initial public offering.
yahoo.com
OFF
CG Oncology Targets Near $1 Billion Valuation In US IPO - Yahoo …
20 hours ago
Jan 18, 2024 · The company is developing a therapy for patients with bladder cancer. Biotech investor ORI Capital and life sciences investor Decheng Capital are its biggest shareholders. …
yahoo.com
OFF
Cancer Drug Developer CG Oncology Valued At $1.75 Billion In
20 hours ago
Jan 25, 2024 · (Reuters) -Cancer drug developer CG Oncology notched up a valuation of $1.75 billion in its market debut on Thursday, after its shares jumped 52.6% at the open, as new …
yahoo.com
OFF
Cancer Drug Developer CG Oncology Valued At $1.75 Bln In Strong …
20 hours ago
Jan 25, 2024 · Cancer drug developer CG Oncology notched up a valuation of $1.75 billion in its market debut on Thursday, after its shares jumped 52.6% at the open, as new listings pick up …
reuters.com
OFF
CG Oncology Lines Up $180m IPO And A $1bn Valuation
20 hours ago
Jan 19, 2024 · CG Oncology joins the queue of US biotech companies hoping to complete an IPO, aiming to raise $181m for its late-stage bladder cancer therapy. ... and if successful will …
pharmaphorum.com
OFF
Cancer Drug Developer CG Oncology Targets Near $1 Bln Valuation …
20 hours ago
Cancer drug developer CG Oncology said on Thursday it was targeting a valuation of nearly $1 billion for its initial public offering. ... -January 18, 2024 at 06:11 am EST - MarketScreener. …
marketscreener.com
OFF
CG Oncology Targets Near $1 Bln Valuation In US IPO
20 hours ago
Cancer drug developer CG Oncology said on Thursday it was targeting a valuation of nearly $1 billion for its initial public offering. The company is developing a therapy for patients...
marketscreener.com
OFF
CG Oncology, Inc. (CGON) Stock Price, Quote & News - Stock …
20 hours ago
4 days ago · CG Oncology valued at $1.75 bln in strong market debut. CG Oncology CGON.O notched up a valuation of $1.75 billion in its market debut on Thursday, after shares of the …
stockanalysis.com
OFF
Cancer Drug Developer CG Oncology Targets Near $1 Billion …
20 hours ago
Jan 18, 2024 · (Reuters) - Cancer drug developer CG Oncology said on Thursday it was targeting a valuation of nearly $1 billion for its initial public offering. (Reporting by Niket Nishant in …
kelo.com
OFF
CG Oncology Valued At $1.75 Bln In Strong Market Debut - Nasdaq
20 hours ago
Jan 25, 2024 · Cancer drug developer CG Oncology notched up a valuation of $1.75 billion in its market debut on Thursday, after its shares jumped 52.6% at the open, as demand for new …
nasdaq.com
OFF
CG Oncology Targets Near $1 Bln Valuation In US IPO
20 hours ago
Jan 18, 2024 · Cancer drug developer CG Oncology said on Thursday it was targeting a valuation of nearly $1 billion for its initial public offering.The company is developing a therapy for …
tradingview.com
OFF
CG Oncology Valued At $1.75 Bln In Strong Market Debut - Yahoo …
20 hours ago
CG Oncology notched up a valuation of $1.75 billion in its market debut on Thursday, after shares of the cancer drug developer rose 52.6% at the open on the Nasdaq.
yahoo.com
OFF
CG Oncology IPO Rockets 96% In Sign Of Pent-up Deal Demand
20 hours ago
Jan 25, 2024 · By Steve Gelsi . Cancer-medicine company closes at $37.17 a share, after pricing at $19 a share in deal that raised $380 million . Cancer-drug company CG Oncology Inc.'s …
morningstar.com
OFF
UPDATE 2-Drug Developer CG Oncology Targets Up To $306 Mln …
20 hours ago
Jan 23, 2024 · Cancer drug developer CG Oncology said on Tuesday it was aiming to raise up to $306 million in its upsized initial public offering in New York, underscoring the resurgent …
yahoo.com
OFF
Drug Developer CG Oncology Targets Up To $306 Mln For Upsized IPO
20 hours ago
Jan 23, 2024 · Adds background, IPO detail in paragraphs 2-6. Jan 23 (Reuters) - Cancer drug developer CG Oncology said on Tuesday it was aiming to raise up to $306 million in its U.S. …
nasdaq.com
FAQs about CG Oncology targets near $1 bln valuation in US IPO | Reuters Coupon?
How much is CG oncology worth?
Will CG oncology raise $306 million?
Who are CG oncology's biggest shareholders?
Where will CG Oncology list its shares?
Is CG oncology a good IPO?
What is CG Oncology's potential therapeutic for?
Install CouponFollow Extension on Chrome
Install the CouponFollow extension to search for discount codes when shopping the fastest!
Install CouponFollow Chrome Extension
Listing Store by Characters
